Page last updated: 2024-10-22

acetazolamide and Thalassemias

acetazolamide has been researched along with Thalassemias in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sakornyutthadej, N1
Mahachoklertwattana, P1
Anantasit, N1
Hongeng, S1
Poomthavorn, P1
Eisenstadt, HB1

Other Studies

2 other studies available for acetazolamide and Thalassemias

ArticleYear
Acetazolamide aggravated diabetic ketoacidosis severity in a boy post-transplantation thalassaemia with intracranial hypertension.
    Journal of paediatrics and child health, 2021, Volume: 57, Issue:3

    Topics: Acetazolamide; Diabetic Ketoacidosis; Humans; Intracranial Hypertension; Male; Thalassemia

2021
Painless hematuria and its cause.
    JAMA, 1972, May-22, Volume: 220, Issue:8

    Topics: Acetazolamide; Bicarbonates; Ethacrynic Acid; Female; Hematuria; Humans; Middle Aged; Thalassemia

1972